Table_5_Microbial Community Response to a Novel Salmon Resource Subsidy.XLSX by Courtney E. Larson (8278182)

“…We found a significant interaction between carcass addition and time on microbial and macroinvertebrate communities. …”

Change of SMAD4 after TGFβ inhibitor /activator treatment. by Jingping Ge (636557)

“…Protein levels were measured by Western blot analysis. A) Decrease of total p-SMAD2 after SB431542 treatment in all iPSCs, and increase of p-SMAD2 in both DBA iPSCs after the TGFβ1 treatment. …”

FOXO3a mediates the downregulation of GR induced by chronic exposure to GCs. by Shi-Ying Yuan (2937669)

“…<p>(A) Representative western blot images and summarized data showing the decreased expression of LKB1 (A) and the inhibitory phosphorylation of FOXO3a-Thr32 (B) in cultured astrocytes (n = 6 for each group). …”

Activation of the vLGN/IGL-LHb-RMTg pathway is required for the ability of bright light treatment to reduce the NREM sleep-promoting effects of chronic stress. by Lu Huang (211625)

The YPLL rate of countries with available data. by Wan Shakira Rodzlan Hasani (9331205)

“…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”

Characteristics of selected studies. by Wan Shakira Rodzlan Hasani (9331205)

“…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”

The SEYLL rate of countries with available data. by Wan Shakira Rodzlan Hasani (9331205)

“…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”

Data extraction form. by Wan Shakira Rodzlan Hasani (9331205)

“…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”

Patterns of SEYLL rate by WHO regions. by Wan Shakira Rodzlan Hasani (9331205)

“…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”

Distribution of selected studies by country. by Wan Shakira Rodzlan Hasani (9331205)

“…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”

Transmission network of the infections of the SARS-CoV-2 Delta variant. by Li Li (14993)

Characteristics of the included medications. by Benazir Hodzic-Santor (14593183)

Table_5_Folic Acid and Risk of Preterm Birth: A Meta-Analysis.DOCX by Bingbing Li (461702)

Secretion of IL-6 and IL-8 in Caco-2 cells treated with cytokines and α-MSH. by Judit Váradi (507449)

P<i>_TET</i>-driven OE of 20 genes results in decreased or increased growth rate. A. Impact of OE on the growth rates of 257 OE strains. by Murielle Chauvel (132263)

“…Genes in orange correspond to those whose OE decreased growth with a fold equal to 2. Data are mean and SD of 3 experiments. …”

Comparing the product effect on changes in body weight of all groups before and after feeding, g. by Fatima Dikhanbayeva (11501962)

Host cellular genes interactions with the SARS-CoV2 proteins. by Amanda Watson (4447267)

Influence of 5-Dihydrotestosterone (DHT) stimulation on L. infantum infection of macrophages. by Annika Bea (17686341)

Summary of the treatment of 43 pediatric oncology patients with 44 episodes of mucormycosis, and those of episodes in which Mucorales infection was or was not considered to be the... by Gabriela A. Marón (17941257)

Disrupting Glycolysis-promoting Genes Extends <i>C</i>. <i>elegans</i> Healthspan, Whereas High Glucose and Gluconeogenic Gene Disruptions Shorten Healthspan. by Brian Onken (86790)

“…Trials with 5 and 13 day old animals also showed impaired older age locomotion in 4% glucose (Supplemental <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.s002" target="_blank">S1A and S1B Fig</a>). …”